Polychrones J
Clarivate, Woodbridge, Virginia, USA.
Drugs Today (Barc). 2020 Aug;56(8):541-554. doi: 10.1358/dot.2020.56.8.3195003.
At the 56th Global Annual Meeting of the Drug Information Association (DIA), attendees met virtually during the height of the global COVID-19 pandemic for "rapid cross-stakeholder, cross-border collaboration" to support health worldwide. Sessions included presenters and speakers from regulatory, patient advocacy and academia sectors, with patients at the forefront of those discussions. This report covers various presentations and panel discussions from the 4-day meeting that focus on COVID-19, innovative trial designs spurred by a need to adapt amid a pandemic, digital health, novel products inspiring new regulatory standards, clinical trials, data collection and management, the need for more and better data and the ever-increasing importance of the patient perspective.
在药物信息协会（DIA）第56届全球年会上，与会者在全球新冠疫情最严重期间以线上方式相聚，进行“快速的跨利益相关方、跨境合作”，以支持全球健康。会议环节包括来自监管、患者权益倡导和学术界的演讲者，患者是这些讨论的核心。本报告涵盖了为期4天会议中的各种演讲和小组讨论，主题集中在新冠疫情、疫情期间适应需求催生的创新试验设计、数字健康、激发新监管标准的新型产品、临床试验、数据收集与管理、对更多更好数据的需求以及患者视角日益增长的重要性。
